Cipla has delivered on its filing for a US Advair generic, garnering a long-sought FDA approval. But with several other players in the US market, the dynamic will be crowded.
Cipla has delivered on its filing for a US Advair generic, garnering a long-sought FDA approval. But with several other players in the US market, the dynamic will be crowded.